Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance

Eur Respir J. 2012 Apr;39(4):802-4. doi: 10.1183/09031936.00171611.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Communicable Disease Control / standards*
  • Communicable Disease Control / trends*
  • Drug Resistance, Bacterial*
  • European Union
  • Humans
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents